2025-08-01 – Press Releases – www.prnewswire.com
This news is for Australian Media only Eflornithine is now reimbursed by the government under Australia’s Pharmaceutical Benefits Scheme (PBS). The Pharmaceutical Benefits Advisory Committee (PBAC) recommended the listing of eflornithine for post-maintenance treatment to prevent relapse…
